In a 23-year-old female with hemoglobin 9.2 g/dL, mean corpuscular volume 69.5 fL, and mean corpuscular hemoglobin 21 pg, what is the likely diagnosis and recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Microcytic Hypochromic Anemia - Iron Deficiency Anemia

This 23-year-old female has iron deficiency anemia (IDA), and you should immediately check serum ferritin and transferrin saturation to confirm the diagnosis, then initiate oral iron supplementation while investigating the underlying cause.

Diagnosis

The laboratory values clearly indicate microcytic hypochromic anemia:

  • Hemoglobin 9.2 g/dL (anemic for women, normal >12 g/dL)
  • MCV 69.5 fL (microcytic, normal 80-100 fL) 1
  • MCH 21 pg (hypochromic, normal 27-31 pg)

Microcytic anemia (MCV <80 fL) is most commonly caused by iron deficiency, though other causes include thalassemia, anemia of chronic disease, and sideroblastic anemia 1. In a 23-year-old woman, iron deficiency is by far the most likely diagnosis.

Confirmatory Testing Required

Serum ferritin is the most powerful test for iron deficiency 2:

  • Ferritin <30 μg/L confirms iron deficiency in the absence of inflammation 3, 4
  • Ferritin <12 μg/L is diagnostic of iron deficiency 2
  • If ferritin is 30-100 μg/L with inflammation present, iron deficiency may still exist 3, 4

Additional confirmatory tests:

  • Transferrin saturation <15-16% supports iron deficiency 1
  • Total iron binding capacity (TIBC) - elevated in iron deficiency
  • Peripheral blood smear - will show microcytic hypochromic red cells

Rule out thalassemia trait: In young women, especially those of Mediterranean, Asian, or African descent, thalassemia can present with microcytosis. Key distinguishing feature: thalassemia typically has elevated or normal red blood cell count despite low MCV, whereas iron deficiency has low RBC count 2. If RBC count is elevated with severe microcytosis, order hemoglobin electrophoresis.

Investigation of Underlying Cause

In premenopausal women, menstrual blood loss is the most common cause of IDA 2. However, you must still evaluate for other causes:

Essential History

  • Menstrual history: Duration, frequency, heaviness of periods (number of pads/tampons per day, clots, flooding)
  • Dietary intake: Vegetarian/vegan diet, overall iron intake
  • GI symptoms: Blood in stool, black stools, abdominal pain, change in bowel habits
  • NSAID use: Can cause occult GI bleeding 2
  • Family history: Thalassemia, bleeding disorders 2

When to Pursue GI Investigation

In a 23-year-old premenopausal woman with heavy menstrual bleeding and no GI symptoms, extensive GI workup is NOT initially required 2. However, pursue upper and lower GI endoscopy if:

  • No history of heavy menstrual bleeding
  • GI symptoms present (blood in stool, abdominal pain)
  • Failure to respond to iron therapy after 3 months
  • Transfusion-dependent anemia 2

If GI investigation is warranted: Upper endoscopy with small bowel biopsies (to exclude celiac disease, present in 2-3% of IDA patients) and colonoscopy 2.

Treatment

First-Line: Oral Iron Supplementation

Start oral iron immediately - ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first choices as they are least expensive 5:

  • Dosing: 100-200 mg elemental iron daily (not twice daily - intermittent dosing is as effective with fewer side effects) 6
  • Take on empty stomach for better absorption, or with meals if not tolerated 5
  • Add vitamin C 500 mg to enhance absorption 5
  • Duration: Continue for 3-6 months to replenish iron stores

Common pitfall: Patients often discontinue oral iron due to GI side effects (nausea, constipation, abdominal pain). Counsel about side effects upfront and consider alternate-day dosing if daily dosing is not tolerated.

Second-Line: Intravenous Iron

Consider IV iron if 5, 6:

  • Cannot tolerate oral iron despite dosing adjustments
  • Malabsorption (celiac disease, inflammatory bowel disease)
  • No response to oral iron after 3 months
  • Severe anemia requiring rapid correction
  • Ongoing blood loss exceeding oral replacement capacity

Contemporary IV iron formulations have rare allergic reactions 6.

Follow-Up

Recheck hemoglobin and ferritin:

  • At 3 weeks: Should see reticulocytosis and rising hemoglobin (therapeutic trial confirms diagnosis) 2
  • At 3 months: Hemoglobin should normalize; ferritin should be rising
  • Continue iron for 3-6 months total to replenish stores even after hemoglobin normalizes

If no response to oral iron: Consider non-compliance, ongoing blood loss, malabsorption, incorrect diagnosis (thalassemia, anemia of chronic disease), or need for IV iron 5.

Address Menstrual Blood Loss

If heavy menstrual bleeding is confirmed as the cause, gynecology referral for management options:

  • Hormonal contraceptives (combined oral contraceptives, levonorgestrel IUD)
  • Tranexamic acid during menses
  • Evaluation for structural causes (fibroids, polyps)

References

1
Guideline

cancer- and chemotherapy-induced anemia.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

6
Research

Iron Deficiency Anemia in Pregnancy.

Obstetrics and gynecology, 2021

Related Questions

What is the appropriate evaluation and management for low hemoglobin with normal mean corpuscular volume (MCV) and normal mean corpuscular hemoglobin concentration (MCHC)?
What is the diagnosis and recommended management for a 33-year-old female with hemoglobin 8.9 g/dL, hematocrit 30.8 %, mean corpuscular volume 69.5 fL, mean corpuscular hemoglobin 20.1 pg, mean corpuscular hemoglobin concentration 28.9 g/dL, red cell distribution width 16.5 %, and platelet count 239 ×10⁹/L?
Given a complete blood count showing hemoglobin 5.7 g/dL, hematocrit 22.6 %, mean corpuscular volume 69.1 fL, mean corpuscular hemoglobin 17.4 pg, mean corpuscular hemoglobin concentration 25.2 g/dL, and red cell distribution width 20.1 %, does the patient need intravenous iron infusion or oral iron supplementation?
What is the most likely diagnosis and recommended work‑up and treatment for a patient with low hemoglobin, low hematocrit, low mean corpuscular volume, high mean corpuscular hemoglobin, and high red‑cell distribution width?
What is the likely diagnosis and appropriate next steps for a CBC with RBC count 5.46 ×10^12/L, mean corpuscular volume 73.6 fL, mean corpuscular hemoglobin 22.5 pg, mean corpuscular hemoglobin concentration 30.6 g/dL, and red cell distribution width 15.5%?
In a patient with refractory acute myeloid leukemia in remission, known liver cirrhosis, recent catheter-related Enterococcus faecium bloodstream infection, possible invasive pulmonary fungal infection (on posaconazole prophylaxis), now presenting with diffuse edema, heart failure, cardiorenal syndrome, multi‑organ failure requiring dialysis, encephalopathy after two days of cefepime, and MRI showing numerous small supratentorial diffusion‑restricted cortical and deep white‑matter lesions with contrast enhancement and subtle pachymeningeal enhancement, what is the differential diagnosis?
What is the appropriate management for a patient with sore throat, normal temperature, cough and cold, elevated C‑reactive protein, neutrophilia (82% neutrophils) and lymphopenia (11% lymphocytes)?
What are the differential diagnoses for an elevated erythrocyte sedimentation rate, neutrophilic granulocytosis on a complete blood count, and increased ferritin in an 83‑year‑old non‑diabetic patient with a pacemaker and dementia?
Does a tetanus booster vaccine interact with methotrexate or biologic agents used for rheumatoid arthritis?
A 21-year-old male presents with three days of fever and hyperbilirubinemia, normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and negative dengue serology; what is the appropriate next step in management?
Which vaccines should a lung transplant candidate receive before transplantation, and what are the recommended timing intervals for each vaccine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.